Nephros, Inc.
General ticker "NEPH" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $43.6M (TTM average)
Nephros, Inc. does not follow the US Stock Market performance with the rate: -6.5%.
Estimated limits based on current volatility of 4.0%: low 3.39$, high 3.67$
Factors to consider:
- Total employees count: 36 (+16.1%) as of 2025
- Top business risk factors: Economic downturns and volatility, Market acceptance, Manufacturing scale up, Supplier dependency, Regulatory and compliance
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.97$, 7.56$]
- 2026-12-31 to 2027-12-31 estimated range: [4.34$, 8.08$]
Financial Metrics affecting the NEPH estimates:
- Positive: with PPE of 44.3 at the end of fiscal year the price was neutral
- Positive: 4.60 < Operating profit margin, % of 6.10
- Positive: 2.37 < Operating cash flow per share per price, % of 3.18
- Positive: Inventory ratio change, % of -0.91 <= -0.37
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: -16.84 < Industry operating profit margin (median), % of -7.42
- Positive: 0.90 < Industry operating cash flow per share per price (median), % of 1.58
- Positive: 7.19 < Return on assets ratio (scaled to [-100,100]) of 8.05
- Positive: -0.14 < Investing cash flow per share per price, % of 0
Short-term NEPH quotes
Long-term NEPH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $14.24MM | $14.16MM | $18.79MM |
| Operating Expenses | $15.83MM | $14.16MM | $17.64MM |
| Operating Income | $-1.59MM | $0.01MM | $1.15MM |
| Non-Operating Income | $0.02MM | $0.08MM | $0.06MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $0.87MM | $0.91MM | $1.34MM |
| Income(Loss) | $-1.57MM | $0.09MM | $1.21MM |
| Taxes | $0.00MM | $0.01MM | $0.01MM |
| Net Income(Loss)* | $-1.57MM | $0.07MM | $1.19MM |
| Stockholders Equity | $8.36MM | $8.59MM | $10.20MM |
| Inventory | $2.47MM | $2.62MM | $3.23MM |
| Assets | $11.86MM | $11.21MM | $13.64MM |
| Operating Cash Flow | $0.83MM | $-0.49MM | $1.65MM |
| Capital expenditure | $0.07MM | $0.06MM | $0.00MM |
| Investing Cash Flow | $-0.07MM | $-0.05MM | $0.00MM |
| Financing Cash Flow | $-0.08MM | $-0.01MM | $-0.01MM |
| Earnings Per Share** | $-0.15 | $0.01 | $0.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.